High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells

Duchenne muscular dystrophy (DMD) is a fatal X-linked muscle wasting disorder arising from mutations in the ~2.4 Mb dystrophin-encoding <i>DMD</i> gene. RNA-guided CRISPR-Cas9 nucleases (RGNs) are opening new DMD therapeutic routes whose bottlenecks include delivering sizable RGN complex...

Full description

Bibliographic Details
Main Authors: Marcella Brescia, Josephine M. Janssen, Jin Liu, Manuel A. F. V. Gonçalves
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/4/869
_version_ 1797571623816003584
author Marcella Brescia
Josephine M. Janssen
Jin Liu
Manuel A. F. V. Gonçalves
author_facet Marcella Brescia
Josephine M. Janssen
Jin Liu
Manuel A. F. V. Gonçalves
author_sort Marcella Brescia
collection DOAJ
description Duchenne muscular dystrophy (DMD) is a fatal X-linked muscle wasting disorder arising from mutations in the ~2.4 Mb dystrophin-encoding <i>DMD</i> gene. RNA-guided CRISPR-Cas9 nucleases (RGNs) are opening new DMD therapeutic routes whose bottlenecks include delivering sizable RGN complexes for assessing their effects on human genomes and testing ex vivo and in vivo <i>DMD</i>-correcting strategies. Here, high-capacity adenoviral vectors (HC-AdVs) encoding single or dual high-specificity RGNs with optimized components were investigated for permanently repairing defective <i>DMD</i> alleles either through exon 51-targeted indel formation or major mutational hotspot excision (>500 kb), respectively. Firstly, we establish that, at high doses, third-generation HC-AdVs lacking all viral genes are significantly less cytotoxic than second-generation adenoviral vectors deleted in <i>E1</i> and <i>E2A</i>. Secondly, we demonstrate that genetically retargeted HC-AdVs can correct up to 42% ± 13% of defective <i>DMD</i> alleles in muscle cell populations through targeted removal of the major mutational hotspot, in which over 60% of frame-shifting large deletions locate. Both <i>DMD</i> gene repair strategies tested readily led to the detection of Becker-like dystrophins in unselected muscle cell populations, leading to the restoration of β-dystroglycan at the plasmalemma of differentiated muscle cells. Hence, HC-AdVs permit the effective assessment of <i>DMD</i> gene-editing tools and strategies in dystrophin-defective human cells while broadening the gamut of <i>DMD</i>-correcting agents.
first_indexed 2024-03-10T20:43:18Z
format Article
id doaj.art-c5a32dfddf4a4d22a011e3bee605c29b
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T20:43:18Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-c5a32dfddf4a4d22a011e3bee605c29b2023-11-19T20:33:40ZengMDPI AGCells2073-44092020-04-019486910.3390/cells9040869High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human CellsMarcella Brescia0Josephine M. Janssen1Jin Liu2Manuel A. F. V. Gonçalves3Department of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The NetherlandsDuchenne muscular dystrophy (DMD) is a fatal X-linked muscle wasting disorder arising from mutations in the ~2.4 Mb dystrophin-encoding <i>DMD</i> gene. RNA-guided CRISPR-Cas9 nucleases (RGNs) are opening new DMD therapeutic routes whose bottlenecks include delivering sizable RGN complexes for assessing their effects on human genomes and testing ex vivo and in vivo <i>DMD</i>-correcting strategies. Here, high-capacity adenoviral vectors (HC-AdVs) encoding single or dual high-specificity RGNs with optimized components were investigated for permanently repairing defective <i>DMD</i> alleles either through exon 51-targeted indel formation or major mutational hotspot excision (>500 kb), respectively. Firstly, we establish that, at high doses, third-generation HC-AdVs lacking all viral genes are significantly less cytotoxic than second-generation adenoviral vectors deleted in <i>E1</i> and <i>E2A</i>. Secondly, we demonstrate that genetically retargeted HC-AdVs can correct up to 42% ± 13% of defective <i>DMD</i> alleles in muscle cell populations through targeted removal of the major mutational hotspot, in which over 60% of frame-shifting large deletions locate. Both <i>DMD</i> gene repair strategies tested readily led to the detection of Becker-like dystrophins in unselected muscle cell populations, leading to the restoration of β-dystroglycan at the plasmalemma of differentiated muscle cells. Hence, HC-AdVs permit the effective assessment of <i>DMD</i> gene-editing tools and strategies in dystrophin-defective human cells while broadening the gamut of <i>DMD</i>-correcting agents.https://www.mdpi.com/2073-4409/9/4/869gene editinggene repairCRISPR-Cas9multiplexinghigh-specificity nucleaseshigh-capacity adenoviral vectors
spellingShingle Marcella Brescia
Josephine M. Janssen
Jin Liu
Manuel A. F. V. Gonçalves
High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells
Cells
gene editing
gene repair
CRISPR-Cas9
multiplexing
high-specificity nucleases
high-capacity adenoviral vectors
title High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells
title_full High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells
title_fullStr High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells
title_full_unstemmed High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells
title_short High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells
title_sort high capacity adenoviral vectors permit robust and versatile testing of i dmd i gene repair tools and strategies in human cells
topic gene editing
gene repair
CRISPR-Cas9
multiplexing
high-specificity nucleases
high-capacity adenoviral vectors
url https://www.mdpi.com/2073-4409/9/4/869
work_keys_str_mv AT marcellabrescia highcapacityadenoviralvectorspermitrobustandversatiletestingofidmdigenerepairtoolsandstrategiesinhumancells
AT josephinemjanssen highcapacityadenoviralvectorspermitrobustandversatiletestingofidmdigenerepairtoolsandstrategiesinhumancells
AT jinliu highcapacityadenoviralvectorspermitrobustandversatiletestingofidmdigenerepairtoolsandstrategiesinhumancells
AT manuelafvgoncalves highcapacityadenoviralvectorspermitrobustandversatiletestingofidmdigenerepairtoolsandstrategiesinhumancells